Bitolterol

Bitolterol

Clinical data
ATC code	R03AC17 (WHO)
Identifiers
IUPAC name [4-(1-hydroxy-2-tert-butylamino-ethyl)- 2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate
CAS Number	30392-41-7
PubChem CID	35330
DrugBank	APRD00827
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C28H31NO5
Molar mass	461.549 g/mol

WikiDoc Resources for Bitolterol
Articles
Most recent articles on Bitolterol Most cited articles on Bitolterol Review articles on Bitolterol Articles on Bitolterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bitolterol Images of Bitolterol Photos of Bitolterol Podcasts & MP3s on Bitolterol Videos on Bitolterol
Evidence Based Medicine
Cochrane Collaboration on Bitolterol Bandolier on Bitolterol TRIP on Bitolterol
Clinical Trials
Ongoing Trials on Bitolterol at Clinical Trials.gov Trial results on Bitolterol Clinical Trials on Bitolterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bitolterol NICE Guidance on Bitolterol NHS PRODIGY Guidance FDA on Bitolterol CDC on Bitolterol
Books
Books on Bitolterol
News
Bitolterol in the news Be alerted to news on Bitolterol News trends on Bitolterol
Commentary
Blogs on Bitolterol
Definitions
Definitions of Bitolterol
Patient Resources / Community
Patient resources on Bitolterol Discussion groups on Bitolterol Patient Handouts on Bitolterol Directions to Hospitals Treating Bitolterol Risk calculators and risk factors for Bitolterol
Healthcare Provider Resources
Symptoms of Bitolterol Causes & Risk Factors for Bitolterol Diagnostic studies for Bitolterol Treatment of Bitolterol
Continuing Medical Education (CME)
CME Programs on Bitolterol
International
Bitolterol en Espanol Bitolterol en Francais
Business
Bitolterol in the Marketplace Patents on Bitolterol
Experimental / Informatics
List of terms related to Bitolterol

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bitolterol mesylate (Tornalate®) is a β₂-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and COPD.

Bitolterol has a rapid onset of action (2-5 minutes) and may last up to 6-8 hours.

Bitolterol was withdrawn from the market by Élan Pharmaceuticals in 2001.

Template:WS